BTG1 deletion occurs in 11%–31.3% of BCP-ALL cases, in 33.3% of MPAL cases, and in 33.3% of CML-BC (B-lineage) cases [176]. Here, BTG1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.